DZP advises ENGIE on the acquisition of five companies with PV projects
Deals corner | 08.09.2023
ENGIE Zielona Energia, a leader on the renewable energy market in Poland, has finalised the third tranche of the purchase of five photovoltaic farms with a total capacity of 12.97 MW. The seller is Columbus Energy, a leading service provider on the modern energy market in Poland.
Foreign subsidies regulation (FSR) and its impact on Chinese investments in Europe
Event | 18.08.2023
On August 18, DZP together with SinoCham – the Polish-Chinese General Chamber of Commerce – organises a seminar on the effects and implications of the Foreign Subsidies Regulation on entities from China that are investing or are interested in investing in Poland.
Abnormally Low Price and State Aid
Publication | 01.08.2023
In the latest issue of the European Procurement & Public Private Partnership Law Review, Wojciech Hartung and Tomasz Zielenkiewicz discuss the impact of State aid received by a contractor on the price the contractor offers in a tender.
Examination of Tenders in Terms of Abnormally Low Price: The Contracting Authority's Perspective
Publication | 28.07.2023
In the latest edition of the European Procurement & Public Private Partnership Law Review, Katarzyna Kuźma, Head of the DZP’s Public Procurement team, discusses the contracting authority's perspective on examination of tenders in terms of abnormally low price.
DZP advises Motherson on the acquisition of Dr. Schneider Automotive Polska
Deals corner | 27.07.2023
DZP has advised Samvardhana Motherson Automotive Systems Group BV on the acquisition of 100% of shares in Dr. Schneider Automotive Poland. The transaction on the Polish market is part of Motherson's global strategy to acquire Schneider Group companies.
DZP advises TZF Polfa on the construction of an Oncology Medicines Development and Manufacturing Centre
Deals corner | 24.07.2023
DZP is advising Tarchominskie Zakłady Farmaceutyczne "Polfa" S.A. on one of the company's largest and most important investments – the construction of an oncology medicines manufacturing facility.